Persistent Systems Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/tml4vlkr4y3k8p7gk9o0jba9.pdf

Key Takeaways


Demand Environment

Kalra: "It is not a race to the bottom where we have to necessarily develop all this IP, deliver more value and pass on everything. That is not the way we are looking at it and that's not the way our customers are looking at it."

Deal Wins & Order Book

Two landmark deals anchor the quarter, one in BFSI and one in Software, Hi-Tech & Emerging, both carrying multiyear tenures and platform-centric delivery models.

DealDetails
Leading American Financial Services company$150 mn+, 7-year deal, the largest transformation deal signed to date, to modernize legacy systems.
UK-based PE-owned software company$50 mn+, 5-year deal to transform R&D operations, with SASVA license and customization as the core tenet.
Global payment technology companySelected to revamp Enterprise Gateway Services.
Large US-based insurerSelected to enhance automation of insurance and claims processes.
Global healthcare leaderSelected to modernize a platform focused on patient care and pharmacy, a new relationship in the UK geography.
Global specialty injectables leaderSole-sourced deal to replace a legacy Contract Management System.
ITSM, observability and database performance providerSelected as engineering partner to alleviate geopolitical business risks and globalize the talent pool.

Vertical Performance

VerticalTrendCommentary
Healthcare & Life Sciences▲ Strong growth52.6% YoY; crossed $100 mn quarterly run rate, meaning all verticals now above that threshold.
BFSI▲ Strong growth22.0% YoY; anchored by the landmark $150 mn+ transformation deal and multiple insurance and payments wins.
Software, Hi-Tech & Emerging▬ Modest growth3.2% YoY; the $50 mn+ SASVA-anchored deal and engineering partnership wins signal platform-led momentum.

AI, Platforms & the Strategic Pivot

The SASVA, iAURA and Gen AI Hub stack

IP and patents

The strategic pivot

Kalra: "The pyramid etc. is going to change over a period of time, not necessarily next quarter, but over the next several quarters and years, you will see the pyramid concept fading away."

Margins

Margin walk (QoQ)Impact
Furloughs–60 bps
Lower earnout credit vs prior quarter (₹15.22 cr reversal)–100 bps
Utilization improvement (84.8% → 87.4%) + contractor cost rationalization + other operational initiatives+140 bps
Strong dollar cross-currency+50 bps
Lower resell revenue + improved pricing+40 bps
Lower ESOP costs+20 bps
Net change → 14.9%+90 bps
Kalra: "If we were to deliver 14.5% for the full year, that means an exit run rate at a different level. That exit run rate for the year becomes an entry run rate for the next year."

People & Operating Model


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue aspiration$2 bn annual revenueBy end of FY27
Revenue aspiration$5 bn in revenueBy FY31
ETR guidance23%–23.5% for the full yearFY25
Earnout reversal provisionExpected to end; Q4 may carry residual, Q1 FY26 noneBy end of FY25
Margin improvement aspiration200–300 bps improvementMedium term, no date given
Europe revenue mixGrow from 8–9% to 12–15%No date given
Platform-driven, outcome-based transitionShift business model toward platform-driven services and outcome-based engagementsOver next several quarters and years

Key Metrics

MetricQ3 FY25
RevenueUS$360.2 million, +19.9% YoY and +4.3% QoQ
Revenue (₹)₹3,062.28 crore, +22.6% YoY and +5.7% QoQ
Constant currency revenue growth4.6% QoQ
EBIT margin14.9%, +90 bps QoQ and +35 bps YoY
EBIT (₹)₹455.73 crore, +25.5% YoY and +12.2% QoQ
Profit after tax margin12.2%
Profit after tax (₹)₹372.99 crore, +30.4% YoY
Earnings per share₹24.30, +28.4% YoY (adjusted for stock split)
Effective tax rate22.6%, vs 25.2% in Q2 FY25; full-year expected 23%–23.5%
Total Contract Value (TCV) bookingsUS$594.1 million, with new bookings TCV of US$333.6 million
Annual Contract Value (ACV) bookingsUS$428.3 million, with new bookings ACV of US$195.6 million
ACV growth (new business)~7% YoY (per an analyst's math)
Total ACV growth~9% YoY (per an analyst's math)
Healthcare & Life Sciences revenue growth52.6% YoY; crossed US$100 million quarterly run rate
Banking & Financial Services revenue growth22.0% YoY
Software, Hi-Tech & Emerging verticals revenue growth3.2% YoY
North America revenue growth21.1% YoY in USD terms
Europe revenue growth10.3% YoY in USD terms
India revenue growth12.1% YoY in USD terms
Rest of world revenue growth66.5% YoY in USD terms, on a low base
Top 10 customer revenue contribution40%, vs 39.3% in Q3 FY24
Top 5 customer revenue growth31.7% YoY
Customers >US$1 million (trailing 12 months)189, vs 176 in Q3 FY24
Utilization87.4%, up from 84.8% in Q2 FY25
Total headcount23,941, +605 YoY
Voluntary attrition (trailing 12 months)12.6%, vs 11.9% in Q3 FY24
Furlough impact on revenue~100 bps
Furlough impact on EBIT margin60 bps headwind
Earnout credit reversal₹15.22 crore, 100 bps headwind to EBIT margin QoQ
Cross-currency tailwind50 bps
Billed DSO64 days, improved 4 days QoQ
Unbilled DSO22 days, improved 2 days QoQ
OCF to PAT ratio84.4%, vs revised 80.7% in Q2 FY25
Return on capital employed (ex-cash)38.1%, vs 35.8% in Q3 FY24
Interim dividend₹20 per share (face value ₹5)
Forward contracts outstandingUS$300 million at average rate of ₹85.30
Large deal win (BFSI)7-year, US$150 million+, largest transformation deal signed
Large deal win (Software, Hi-Tech)5-year, US$50 million+